North-south differences in US emergency department visits for acute allergic reactions
Received 6 January 2010; received in revised form 25 January 2010; accepted 29 January 2010.
Background
In a previous study, latitude was positively associated with EpiPen prescription rates.
Objective
To determine whether a similar geographic difference exists for emergency department (ED) visits for acute allergic reactions (including anaphylaxis).
Methods
We combined National Hospital Ambulatory Medical Care Survey data for ED visits to noninstitutional hospitals from 1993 to 2005. Acute allergic reactions were identified by International Classification of Diseases, Ninth Revision, Clinical Modification codes 995.0, 995.60-995.69, 995.1, 995.2, 995.3, 989.5, and 693.1, and visit rates were compared across standardized geographic divisions.
Results
Between 1993 and 2005, there were 17.3 million ED visits for acute allergic reactions, representing 1.3% (95% confidence interval [CI], 1.2%-1.3%) of all ED visits. Per 1000 population, the Northeast had 5.5 visits (95% CI, 4.7-6.2 visits) and the South had 4.9 visits (95% CI, 4.3-5.6 visits). In a multivariable model, the Northeast had a higher odds ratio (OR) than the South (1.13; 95% CI, 1.01-1.27; P = .04). The association was stronger when restricting the analysis to visits for food-related allergic reactions (OR, 1.33; 95% CI, 1.14-1.56; P < .001).
Conclusions
The ED visit rates for acute allergic reactions are higher in northeastern vs southern regions. These observational data are consistent with the hypothesis that vitamin D may play an etiologic role in anaphylaxis, especially food-induced anaphylaxis.
⁎Division of Allergy and Immunology, Children's Hospital Boston, Boston, Massachusetts
†Department of Emergency Medicine, Massachusetts General Hospital, Boston, Massachusetts
‡Division of Rheumatology, Allergy, and Immunology, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts
§Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts
Reprint requests should be addressed to: Carlos A. Camargo Jr, MD, DrPH, Massachusetts General Hospital, 326 Cambridge St, Ste 410, Boston, MA 02114
Disclosures: Dr. Rudders is supported by NIH training grant NRSA T32-AI-007512 (Bethesda, USA). Dr Camargo is supported, in part, by the Massachusetts General Hospital Center for D-receptor Activation Research (Boston, USA).
ABSTRACT